Heath KV - Search Results

1

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.

Recsky MA, Brumme ZL, Chan KJ, Wynhoven B, Yip B, Dong WW, Heath KV, Montaner JS, Levy AR, Hogg RS, Harrigan PR. Recsky MA, et al. Among authors: heath kv. J Infect Dis. 2004 Jul 15;190(2):285-92. doi: 10.1086/422007. Epub 2004 Jun 11. J Infect Dis. 2004. PMID: 15216463

2

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.

Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, Montaner JS. Hogg RS, et al. AIDS. 2002 May 3;16(7):1051-8. doi: 10.1097/00002030-200205030-00012. AIDS. 2002. PMID: 11953472

3

Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.

Toulson AR, Harrigan R, Heath K, Yip B, Brumme ZL, Harris M, Hogg RS, Montaner JS. Toulson AR, et al. J Infect Dis. 2005 Nov 15;192(10):1787-93. doi: 10.1086/491738. Epub 2005 Oct 5. J Infect Dis. 2005. PMID: 16235178

4

Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, Canada.

Nosyk B, Colley G, Yip B, Chan K, Heath K, Lima VD, Gilbert M, Hogg RS, Harrigan PR, Montaner JS; STOP HIV/AIDS Study Group. Nosyk B, et al. PLoS One. 2013;8(1):e54416. doi: 10.1371/journal.pone.0054416. Epub 2013 Jan 28. PLoS One. 2013. PMID: 23382898 Free PMC article.

5

The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study.

Nosyk B, Montaner JSG, Colley G, Lima VD, Chan K, Heath K, Yip B, Samji H, Gilbert M, Barrios R, Gustafson R, Hogg RS; STOP HIV/AIDS Study Group. Nosyk B, et al. Lancet Infect Dis. 2014 Jan;14(1):40-49. doi: 10.1016/S1473-3099(13)70254-8. Epub 2013 Sep 27. Lancet Infect Dis. 2014. PMID: 24076277 Free PMC article.

6

Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort.

Heath KV, Hogg RS, Singer J, Chan KJ, O'Shaughnessy MV, Montaner JS. Heath KV, et al. J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):440-7. doi: 10.1097/00042560-200208010-00010. J Acquir Immune Defic Syndr. 2002. PMID: 12138351

7

Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy.

Heath KV, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS. Heath KV, et al. J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):211-7. doi: 10.1097/00126334-200210010-00012. J Acquir Immune Defic Syndr. 2002. PMID: 12394800

8

Incidence of morphological and lipid abnormalities: gender and treatment differentials after initiation of first antiretroviral therapy.

Heath KV, Chan KJ, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS. Heath KV, et al. Int J Epidemiol. 2002 Oct;31(5):1016-20. doi: 10.1093/ije/31.5.1016. Int J Epidemiol. 2002. PMID: 12435777

9

Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000.

Braitstein P, Yip B, Heath KV, Levy AR, Montaner JS, Humphries K, Kiely FM, O'Shaughnessy MV, Hogg RS. Braitstein P, et al. Among authors: heath kv. AIDS. 2003 Sep 26;17(14):2071-5. doi: 10.1097/00002030-200309260-00008. AIDS. 2003. PMID: 14502010

10

Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.

Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS. Bedell R, et al. Among authors: heath kv. Antivir Ther. 2003 Oct;8(5):379-84. Antivir Ther. 2003. PMID: 14640384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters